Sophia Genetics
The SOPHiA DDM™ Platform, powered by AI, allows secure access to genomic data for global healthcare institutions, advancing diagnostics, therapy choice, & research through collaboration.
Sophia Genetics is a professional services company offering the SOPHiA DDM™ Platform, an AI-powered healthcare analytics solution for global institutions, enabling safe access to data while retaining ownership and providing valuable insights from multimodal datasets. The platform covers various applications in oncology, rare diseases, bioPharma, and more, integrating with LIMS and EHRs. Sophia Genetics also provides Alamut™ Visual Plus and OncoPortal™ Plus for genomic data visualization and interpretation. Their customer base of 750+ institutions collaborates to build a collective intelligence in healthcare analytics.
About Sophia Genetics
Sophia Genetics is a professional services company that develops and provides the SOPHiA DDM™ Platform, a multimodal genomics solution for healthcare institutions worldwide. Powered by AI and machine learning, this universal healthcare analytics platform offers a safe, secure, and instantly accessible environment for standardizing, computing, and analyzing digital health data. With a global footprint spanning over 70 countries and 1.5 million+ genomic profiles analyzed, Sophia Genetics enables its customers to retain ownership of their data while accessing valuable insights from complex multimodal data sets.
The SOPHiA DDM™ Platform encompasses solutions for various applications, including oncology, rare and inherited diseases, bioPharma, and resources such as publications, case studies, webinars, and a science hub. By integrating with Laboratory Information Management Systems (LIMS) and Electronic Health Records (EHRs), the platform supports clinical analysis and drug development for solid tumors, blood cancers, hereditary cancers, liquid biopsy, CE-IVD applications, cardiovascular diseases, metabolism, neurological disorders, pediatric diseases, pharmacogenomics, rare diseases, and various other health conditions.
Sophia Genetics' offerings also include Alamut™ Visual Plus and OncoPortal™ Plus, which are essential tools for visualizing, interpreting, and integrating genomic data to improve diagnosis, therapy selection, and research in the fields of oncology, rare and inherited diseases, and bioPharma. By sharing insights with each other, Sophia Genetics' customer base of 750+ healthcare institutions is able to grow a collective intelligence that drives innovation in healthcare analytics.
